OBESITY AND METABOLIC DISEASE
THE UNMET NEED
More than 30% of the American population is obese.1
Obesity is a leading cause of morbidity and mortality in westernized societies.
65 million more adults in the US will be obese by 2030.2
THE PIONEERING SOLUTION
Whole Biome are working on a pre- and pro-biotic formulation to address obesity and type 2 diabetes. Their treatments are now entering clinical trials at four sites across the United States.
The company has several products that have been developed and are in beta testing in the marketplace.
Investors in Whole Biome include Sequoia Capital, Khosla Ventures, Mayo Clinic Ventures, True Ventures, Data Collective Venture Capital - and LifeX Capital.
1. Flegal KM et al. JAMA 2012; 307(5): 491–497. 2. 'Half of UK obese by 2030' https://www.nhs.uk/news/obesity/half-of-uk-obese-by-2030/ Accessed April 2018.